Whole exome sequencing revealed a novel homozygous variant in the DGKE catalytic domain: a case report of familial hemolytic uremic syndrome.
DGKE
Hemolytic-uremic syndrome
Protein computational analysis
Whole exome sequencing
Journal
BMC medical genetics
ISSN: 1471-2350
Titre abrégé: BMC Med Genet
Pays: England
ID NLM: 100968552
Informations de publication
Date de publication:
24 08 2020
24 08 2020
Historique:
received:
10
10
2019
accepted:
28
07
2020
entrez:
26
8
2020
pubmed:
26
8
2020
medline:
3
11
2020
Statut:
epublish
Résumé
Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by microangiopathic hemolytic anemia caused by small vessel thrombosis, thrombocytopenia, and renal failure. The common cause of aHUS is a dysregulation in the alternative complement pathway. Mutations in none complement genes such as diacylglycerol kinase epsilon (DGKE) can also result in this syndrome. Here, we report on a 19-year-old female with the clinical diagnosis of aHUS, who has unaffected consanguineous parents and an older sibling who was deceased from aHUS when she was seven months old. We performed whole exome sequencing (WES) followed by evaluation of detected variants for functional significance, using several online prediction tools. Next, in order to confirm the detected pathogenic variant in proband and segregation analysis in her family, Sanger sequencing was done. The novel variant was analyzed in terms of its impact on the protein 3-dimensional structure by computational structural modeling. The results revealed that the proband carried a novel homozygous missense variant in DGKE located in exon 6 of the gene (NM_003647.3, c.942C > G [p.Asn314Lys]), and in silico analysis anticipated it as damaging. Protein computational study confirmed the influence of potential pathogenic variant on structural stability and protein function. We suggest that some variations in the catalytic domain of DGKE like p.Asn314Lys which can cause alterations in secondary and 3-D structure of protein, might lead to aHUS.
Sections du résumé
BACKGROUND
Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by microangiopathic hemolytic anemia caused by small vessel thrombosis, thrombocytopenia, and renal failure. The common cause of aHUS is a dysregulation in the alternative complement pathway. Mutations in none complement genes such as diacylglycerol kinase epsilon (DGKE) can also result in this syndrome.
CASE PRESENTATION
Here, we report on a 19-year-old female with the clinical diagnosis of aHUS, who has unaffected consanguineous parents and an older sibling who was deceased from aHUS when she was seven months old. We performed whole exome sequencing (WES) followed by evaluation of detected variants for functional significance, using several online prediction tools. Next, in order to confirm the detected pathogenic variant in proband and segregation analysis in her family, Sanger sequencing was done. The novel variant was analyzed in terms of its impact on the protein 3-dimensional structure by computational structural modeling. The results revealed that the proband carried a novel homozygous missense variant in DGKE located in exon 6 of the gene (NM_003647.3, c.942C > G [p.Asn314Lys]), and in silico analysis anticipated it as damaging. Protein computational study confirmed the influence of potential pathogenic variant on structural stability and protein function.
CONCLUSION
We suggest that some variations in the catalytic domain of DGKE like p.Asn314Lys which can cause alterations in secondary and 3-D structure of protein, might lead to aHUS.
Identifiants
pubmed: 32838746
doi: 10.1186/s12881-020-01097-9
pii: 10.1186/s12881-020-01097-9
pmc: PMC7446132
doi:
Substances chimiques
DGKE protein, human
EC 2.7.1.107
Diacylglycerol Kinase
EC 2.7.1.107
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
169Subventions
Organisme : Iran University of medical sciences (IUMS)
ID : 96-4-30-32441
Pays : International
Références
Front Cell Dev Biol. 2016 Oct 18;4:112
pubmed: 27803897
Mol Biol Rep. 2019 Jun;46(3):3417-3426
pubmed: 30982216
BMC Bioinformatics. 2010 Nov 08;11:548
pubmed: 21059217
Mol Genet Metab. 2018 May;124(1):87-93
pubmed: 29661558
Pediatr Clin North Am. 2018 Jun;65(3):509-525
pubmed: 29803280
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
Nat Genet. 2013 May;45(5):531-6
pubmed: 23542698
Semin Immunopathol. 2018 Jan;40(1):49-64
pubmed: 29327071
Bioinformatics. 2015 Aug 15;31(16):2745-7
pubmed: 25851949
J Med Genet. 2012 Jul;49(7):433-6
pubmed: 22717648
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):217-225
pubmed: 27913483
Front Med (Lausanne). 2014 Dec 12;1:52
pubmed: 25593925
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Genet Med. 2017 Oct;19(10):1105-1117
pubmed: 28492532
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Nat Rev Nephrol. 2015 Apr;11(4):245-52
pubmed: 25599621
Pediatr Clin North Am. 2019 Feb;66(1):235-246
pubmed: 30454746
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Circ Cardiovasc Genet. 2011 Dec;4(6):585-94
pubmed: 21965549
Eur J Intern Med. 2013 Sep;24(6):496-502
pubmed: 23743117